Is it safe to use lagundi (Vitex negundo), cetirizine, and ambroxol while breastfeeding?

Cetirizine and Ambroxol Are Acceptable During Breastfeeding; Lagundi Should Be Avoided Due to Insufficient Safety Data

Cetirizine is safe to use while breastfeeding, with minimal transfer into breast milk and no significant risk to the infant. Ambroxol can be used with standard precautions. However, lagundi (Vitex negundo) should be avoided during breastfeeding due to lack of safety data.

Cetirizine - Safe for Breastfeeding

The evidence strongly supports cetirizine use during lactation:

• Transfer into breast milk is very low: A 2024 human lactation study found mean maximum cetirizine milk concentrations of only 41.0 μg/L, with peak levels occurring 2.4 hours after intake 1

• Infant exposure is minimal: The relative infant dose (RID) is only 1.9%, well below the 5% safety threshold considered acceptable for breastfeeding 1

• No adverse effects reported: The study documented no severe adverse events in breastfed infants 1

• Systematic review confirms safety: A 2022 review of antihistamines during breastfeeding found RID values below 5% for all studied antihistamines, confirming compatibility with breastfeeding 2

Important caveat: The FDA label states cetirizine is "not recommended" during breastfeeding 3, but this reflects regulatory conservatism rather than actual safety data. The clinical evidence demonstrates safety.

Ambroxol - Acceptable with Standard Monitoring

While the provided evidence doesn't specifically address ambroxol during breastfeeding, general principles apply:

• Mucolytics are commonly continued during breastfeeding for maternal respiratory conditions
• Standard monitoring of the infant for any unusual symptoms is appropriate
• The benefit of treating maternal respiratory symptoms typically outweighs theoretical risks

Lagundi (Vitex negundo) - Avoid During Breastfeeding

Lagundi should not be used while breastfeeding for the following reasons:

• No human safety data: The FDA label explicitly states "If pregnant or breastfeeding, ask a healthcare professional before use" 4, indicating lack of established safety

• Insufficient lactation studies: Recent comprehensive reviews of V. negundo (2015-2025) make no mention of safety during lactation 5, 6

• Traditional use does not equal safety data: While lagundi has traditional medicinal uses, this does not establish safety for nursing infants

• Alternative treatments available: For respiratory symptoms, safer alternatives with established breastfeeding safety profiles exist (such as cetirizine for allergic symptoms)

Clinical Approach

For a breastfeeding mother needing these medications:

1. Cetirizine: Use standard adult dosing (10 mg daily). Time the dose immediately after breastfeeding to minimize infant exposure, though this is not strictly necessary given the low transfer rates

2. Ambroxol: Can be used at standard doses with routine infant monitoring for drowsiness or feeding changes

3. Lagundi: Recommend discontinuation and substitute with evidence-based alternatives for the specific indication (e.g., cetirizine for allergic rhinitis, other mucolytics with better safety data for cough)

4. Monitor the infant for any signs of drowsiness, irritability, or feeding difficulties, though these are unlikely with cetirizine

Common pitfall to avoid: Don't rely solely on FDA labeling for breastfeeding decisions, as labels often reflect lack of data rather than evidence of harm. The clinical research demonstrates cetirizine safety despite conservative FDA labeling 1.